Atreca, Inc. announced tha Tito A. Serafini, Ph.D., ceased to serve as the Chief Strategy Officer of the Company, effective January 31, 2024. Dr. Serafini remains a member of the Board of Directors of the Company. In connection with the wind down of the operations of the Company, Stephen E. Gould, Ph.D., ceased to serve as the Chief Scientific Officer of the Company, effective December 31, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.08 USD | -6.43% | +3.90% | -39.39% |
Apr. 17 | North American Morning Briefing : Stock Futures -2- | DJ |
Apr. 10 | North American Morning Briefing : Traders Await -2- | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-39.39% | 3.17M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- BCEL Stock
- News Atreca, Inc.
- Atreca, Inc. Announces Board Resignations